Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Using cidofovir cream for a rare skin disease can cause skin darkening.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

TTD patients don't have a higher skin cancer risk because their main issue is with transcription, not DNA repair.

Tay syndrome is a unique genetic disorder causing skin, hair, and developmental issues.

The treatment was not recommended due to limited effectiveness and significant side effects.

Trichodysplasia spinulosa is a rare skin condition linked to weakened immune systems, mostly in organ transplant patients.

Arsenic trioxide effectively treats relapsed acute promyelocytic leukemia with manageable side effects.

Sonidegib effectively treated basal cell carcinoma in a patient with lupus without worsening lupus symptoms.

A man with a weakened immune system was diagnosed with a rare skin condition called trichodysplasia spinulosa using skin examination techniques.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

The drug combination was safe and showed promise in treating advanced tumors.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Deferasirox effectively reduces iron overload in ß-thalassemia patients but may cause some manageable side effects.

Reducing immunosuppression and using antiviral creams improved the woman's skin condition.

PEGylated thymosin β4 shows promise for treating heart attacks effectively.

Effective treatment for UFT overdose includes antibiotics and G-CSF, with bone marrow biopsy and transfusion as backup options.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Antituberculosis drugs can cause severe skin reactions, requiring careful diagnosis and treatment.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Trichodysplasia spinulosa is a rare skin disease in immunocompromised patients caused by a specific virus targeting hair follicle cells.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

CTP-543 is generally safe for treating alopecia areata.

Sirolimus can reduce tumor cell size in TSC-related skin tumors, but continuous treatment is needed to maintain benefits.